Page last updated: 2024-08-24

aripiprazole and Callous-Unemotional Traits

aripiprazole has been researched along with Callous-Unemotional Traits in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	4 (57.14)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Biederman, J; Cook, E; DiSalvo, M; Faraone, SV; Farrell, A; Joshi, G; Wozniak, J; Yule, A	1
Argüz Çildir, D; Kalyoncu, T	1
Amatniek, J; Calabrese, JR; Carson, WH; Cox, K; Hertel, P; Jin, N; Johnson, B; McQuade, RD; Nyilas, M; Perry, PP; Sanchez, R; Such, P	1
Connolly, JG; Schneeweiss, MC; Toomey, TJ	1
Assuncao-Talbott, S; Blumer, J; Boulton, DW; Findling, RL; Iwamoto, T; Kauffman, R; Kollia, G; Kornhauser, DM; Mallikaarjun, S; McQuade, RD; Sahasrabudhe, V; Salazar, DE; Sallee, FR; Vachharajani, NN	1
Barnett, M; Calarge, C; Holman, T; Kolar, A; Kuperman, S; Perry, P	1
Carlson, BX; Eudicone, J; Frye, MA; Marcus, RN; McQuade, RD; Pikalov, A	1

Trials

2 trial(s) available for aripiprazole and Callous-Unemotional Traits

Article	Year
The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study. Journal of affective disorders, 2018, 12-01, Volume: 241 Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Psychomotor Agitation; Substance Withdrawal Syndrome; Weight Gain; Young Adult	2018
An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2011, Volume: 23, Issue:4 Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Conduct Disorder; Humans; Male; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome	2011

Article

Year

The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study.

Journal of affective disorders, 2018, 12-01, Volume: 241

Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Female; Humans; Maintenance Chemotherapy; Male; Middle Aged; Psychomotor Agitation; Substance Withdrawal Syndrome; Weight Gain; Young Adult

2018

An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2011, Volume: 23, Issue:4

Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Conduct Disorder; Humans; Male; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome

2011

Other Studies

5 other study(ies) available for aripiprazole and Callous-Unemotional Traits

Article	Year
Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole. Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:5 Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Clinical Trials as Topic; Conduct Disorder; Humans; Mania; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Risperidone; Thiazoles	2022
Trichotillomania Associated With Aripiprazole: A Case Report. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:1 Topics: Adolescent; Adolescent Behavior; Aripiprazole; Conduct Disorder; Dopamine Agonists; Humans; Irritable Mood; Male; Trichotillomania	2018
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011. Psychiatric services (Washington, D.C.), 2015, Volume: 66, Issue:6 Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles	2015
An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder. Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:4 Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Child; Conduct Disorder; Female; Follow-Up Studies; Humans; Male; Piperazines; Prospective Studies; Quinolones; Tremor; Vomiting	2009
Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Topics: Affective Symptoms; Aggression; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Conduct Disorder; Double-Blind Method; Humans; Irritable Mood; Mood Disorders; Multicenter Studies as Topic; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome	2008